Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + Chemotherapy in Advanced Lung Adenocarcinoma
NCT02804646Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of endostar in lung adenocarcinoma, sponsored by The First Affiliated Hospital of USTC. Status: unknown.
02
Drugs
endostar
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT02804646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02804646.